2024 rideATAXIA Philly and FARA & CHOP FA Symposium Recap
Events
Blog|Oct 28 2024
Meet The Community: Daniel Huber
Community
Blog|Oct 21 2024
Meet The Community: Kendall Harvey
Community
News|Oct 16 2024
Papillon Therapeutics Receives Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich’s Ataxia
Industry News
Blog|Oct 14 2024
2024 rideATAXIA Hometown Twin Cities, MN Recap
Events
News|Oct 8 2024
PTC Therapeutics Announces Positive Results from Long-Term Treatment Studies and Updates on Regulatory Progress for Vatiquinone Friedreich Ataxia Program
Industry News
Blog|Oct 4 2024
Meet the Community 2: A Closer Look — Alijana Shakya
Community
Blog|Sep 30 2024
2024 Fuzzy Buzzy Recap
Events
Blog|Sep 23 2024
Meet the Community 2: A Closer Look – Alex Fielding
Community
News|Sep 20 2024
Congressional Resolution Passes to Designate September 25 as “National Ataxia Awareness Day”
Advocacy
News|Sep 17 2024
Papillon Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich’s Ataxia